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THE RH FACTORS 
INTRODUCTION 
Many years ago Landsteiner conceived the 
existence of numerous serologic ~ifferences in 
human blood,which, in a manner similar to finger-
printing, might someday make it possible to identify 
the'individual (1). Since his discovery of the 
human blood groups in 1900 many agglutinable factors 
have been reported in human erythrocytes such as M, 
N, l', G, H, X; Q, E; Rh (2) and Hr (.zo). During the 
l·ast five years the Rb. factor and more recently the 
Hr factor have received considerable attention and 
well over two hundred and fifty papers have been 
written about them. Several of the earlier articles, 
especially those in 1941 and 1942, have drawn erron-
eous or incomplete conclusions because of inadequate 
case material and testing sera. However, much sig-
ni~icant material concerning these factors, Rh and 
Hr, pas been established, and with the more recent 
findings many of the unsolved problems have been 
• 
solved. 
It is the purpose of this paper to review 
the more important facts and the latest concepts con-
cerning the Rh factors and to discuss briefly the 
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Hr factor. No attempt will be made to consider the 
clinical aspects in detail as these will be well 
presented in another paper. 
' 
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HISTORY OF THE RH FACTORS AND ANTI-RH AGGLUTININS 
In 1937 Landsteiner and Wiener (1, 4) in-
jected red cells of the rhesus monkey into a rabbit 
and produced an immune serum which was found to agglu-
tinate 39 out of 45 human bloods independent of the 
M, N, and P factors, Ttiis property of human blood 
agglutinated by the anti-Rhesus sera was designated 
as Rh and those human cells agglutinated as Rh ;. 
Human cells not reacting wit4 this anti-serum were 
therefore Rh • (5). 
Following the discovery of the Rh factor 
Wiener and Peters (14) observed a fatal transfusion 
reaction in a 53 year old Rh- female and obtained 
agglutinins from her blood which clumped the donor's 
red cells. The patient had received four transfusions 
from this Rhi donor without any visible signs of in-
• 
compatibility but after the fifth transfusion there 
followed a febrile reaction, hemoglobinuria, oliguria, 
jaundice and a rise of the N~T. The agglutination 
reactions between the patient's agglutinins and the 
red cells of the dqnor and other Group 0 bloods were 
w~aker than Group A and B isoagglutination reactions 
and were more pronounced at a low temperature. Since 
these reactions were similar to those of anti-Rhesus 
immune rabbit serum, the agglutinin was called anti-
Rh. It is of interest to note that the reactions 
were better at a low temperature which in the light 
o~ more recent findings might suggest the presence of 
blocking antibodies ( to be discussed later.). Levine 
et al. (15, 16, 17) also noticed atypical agg-lutinins 
in sera from a number of patients which seemed to react 
better at 37° C. than at the low temperature. The 
specificity of most of these sera ~orresponded to the 
anti-Rhesus serum of Landsteiner and Wiener (1, 4). 
In 1942 Wiener (18) found a serum in a patient 
with an intragroup hemolytic reaction which gave 
twice as many negative reactions as were obtained with 
anti-Rh serum. Also bloods negative with anti-Rh serUm 
were usually negative with this serum. Since it com-
pared in its behaviour to anti-At, Wiener designated 
this serum anti-Rh~ and bloods agglutinated by it as 
Rh~. Bloods agglutin~ted only by anti-Rh serum were 
called Rh2. Back in 1941 Landsteiner and Wiener (19) 
obtained a similar serum from a post transfusion case 
which gave many more negative reactions with blood 
samples than did anti-Rh serum. Consequently their 
serum might also have been anti-Rh~. 
'l. 
Anti-Rht agglutinins were first observed by 
Wiener (33) and Levine et al (20) in 1941 but were 
not named as such. These atypical agglutinins were 
found to be related to the Rh factor but ~ave slightly 
different reactions with test bloods than wer~ obtained 
with standard anti-Rh serum (33). Several years later 
Wiener and Landsteiner (21) used this anti-Rh~ se~um 
in conjunction with anti-Rh and anti-Rh1 sera to c,lass ... 
Uh · ifyA~loods into different subtypes (See Table No.1). 
Fisk and Foord ~) found an antiserUf'l in the mother 
' . 
of an erythroblastotic infant which gave ?O% posit,ive 
reactions with Rh~ cells. They concluded that this 
antiserel'l.was similar to that found by Wiener (33) 
and Levine et al. (20) which gave 8?% positive reac-
tions {21). In view of the present terminology the 
. ~l( 
anti-Rh' serum of Fisk and Foord (~) gives a more 
t!l' 
correct percentage of positive reactions (of. Table t.). 
Wiener and Sonn(22) observed a patient who 
was A~Rh~ and had delivered an erythroblastotic baby. 
They found a special agglutinin in her blood which 
was different from the anti-Rh', and anti-Rh1 aggl~t­
inins. After testing this special antisera with diff-
, 
erent bloods (of. Table No. 2) they suggested that 
the aggluti'nogen determined by the new antisera was 
Table 1 
Early Classification of Bloods(Rh)* 
Antisera 
Anti- Rh 
Anti- Rhl 
Anti- Rh' 
% of f Reactions 
84% 
73% 
87% 
*Modified from Wiener(21) 
Bloods Tested 
~ f t 
~ ~ ~ 
Rh1 Rh2 Rh-
.........._J 
Rh' 
~
Rhf 
G.. 
7. 
Table 2 
Correlation of Anti-Rh Terminology 
Previous % of f. Present % of f 
Terminology Reactions Investigators Terminology* Reactions* 
Anti-Rh2 30% 
. t (:Z'-) Anti-Rh'' 30% w~ener e al. 
Race et al. l:~c-) 
Anti-Rh 84% Landsteiner & Anti-Rho. - 1 85% 
Wiener (•.<~) 
Levine et al ~r,u.,n) 
Wiener & 
Peters (tt.~) 
Anti-Rhi 73% Wienef (t'l) Anti-Rh<! '73% 
Wiener & 
Landsteiner{t'l) •! 
Anti-Rhf 87% Wiener (:n) Anti-Rh 87% 
Levine ('-o) 
*From Diampnd(5) 
Table 3:: 
New A,ntiserurn(Rh2 ) Tested with Known Bloods* 
Blood 
Rhl 
Rh2 
Rh-
Results 
28.5% pos. 
78.3% pos. 
o% pos. 
*From Wiener(22) 
71.5% neg. 
21.7% neg. 
100% neg. 
0 
0 
either Rh2 or related to Rh2 and therefore de.signated 
the serum as anti-Rh2• With anti-Rh2 Wiener (23) was 
able to subdivide Rh1 and Rh2 bloods into four types 
{ See Table No. 9 ) • 
. R~ce et al. (25) working in England obtained 
a serum from a mother of an erythroblastotic child 
which.gave positive reactions with 30% of the pop-
ulation and called it KJ. Using antisera Rh1, St 
( .to be described later ) , an:d KJ, they postulated 
two other Rh factors, Rhx and Rhy, the former giving 
negative, positive, and positive reactions respectively 
with these antisera. However, Lou~it (26) noticed 
that KJ antiserum was s~ilar to Wiener's 'anti-Rh2 
(22) and that R~~ corresponded to Wiener's Rh't• 
In 1944 Race et al (29) encountered a serum 
which when used with~, St, and Rh1 antisera gave 
two additional Rh allelomorphs, Rh
0 
and Rhf. This 
, . serum corresponded with Wiener's anti-Rh1 (18) and 
the Rh0 factor with Wienew•s Rh which he had been 
able to differentiate with his anti-Rh2 (23). The 
Rh' factor had already been named by Wiener and 
Landsteiner (21). 
The Rh type of blood in general is named 
after the antisera. with which it reacts (27). Therefore,· 
,. 
jO, 
Table 4 
Subdivision of Rh1 and Rh2 Bloods with Rh2 Antiser~~ 
Previous Type Anti-Rh2 Resulting Type 
Rh1 1 Rh1Rh2 
-
Rh 
Rh2 f Rh
1 
Rh2 
*From Wiener(23) 
0 
0 
when antisera Rh', Rh'', and Rh0 are used, eight Rh 
types can be differentiated (28). (See Table No.5) 
The blocking antibody was first considered 
in 1941 by Wiener (30) who noticed the absence of any 
demonstrable anti-Rh agglutinins in the plasma of 
patients who were either suffering from hemolytic 
transfusion reactions or who had delivered erythro-
blastotic infants. He tried several blocking experi-
ments with the serum of the patients described by 
Wiener and Peters ( 14). The resul ts··were irregular 
but did show the blocking o~ active agglutinins by 
some antibody still present in the patients' serum. 
Three years later, when better anti-Rh testing serum 
was available, similar tests were carried out with 
clear cut blocking reactions; thus proving the exis-
tence of some special Rh antibody which is now known 
as the blocking antibody. 
In this same year Race and Taylor (31) found 
~ Rh an til5ody which would combine with homologous 
red blood cells in vitro but would not agglutinate 
them. They called this Rh antibody an incomplete anti-
body which corresponds to the blocking antibody. 
Further experiments (40} showed that anti-Rh1 serum 
would block antigen D ( See later discussion for Fisherts 
Table 5 
Eight Blood Types(Rh) and Reactions* 
Type 
Rh 
RhQ {Rho') 
Rh2 (Rh0 ~!) Rh Rh ( Rh~ iill0 ") Rh-
Rh' 
Rh'' 
Rh'Rh'' 
.Anti-Rh' 
... 
f 
... 
1-
.... 
.;. 
-
.;. 
Antisera 
Anti-Rh'' 
-
*Modified from Wiener{28) 
Anti-Rho 
~ ~ 
... 
/~. 
terminology) of Rh2 cells making it impossible to show 
agglutination with standard anti-Rh serum which it 
does show if Rh2 cells are not previously blocked. The 
E·and c antigens are left uncoated ready for agglutin-
ation. Absorption with untreated Rh2 cells diminishes 
the agglutinin titer of standard anti~Rh serum while 
absorption with coated Rh2 cells does not diminish the 
titer. Therefore, " the coating factor may be looked 
on as the standard anti~Rh serum antibody {A),which can 
combine with its appropriate antigen but is defective 
in that it is not a suitable partner for the second 
stage of the antibody-antigen reaction which results 
in agglutination of the cells. " (40) This coating 
factor was called the incomplete antibody which is sim~ 
ilar in action to the blocking antibody. Race {40) 
was also able to coat the D antigen in Rh1 Rh2 ~ Rh1 Rh1~ 
Rh1 rh, Rh2 rh, Rhz Rh2 and Rh0 rh cells and further 
found that this incomplete antibody which is relatively 
stable at 56° c. could be removed from serum by appropa 
riate cells. 
Diamond and Abelson (4?} noticed that the action 
et Rh antisera appeared to be lost when they attempted 
to pool anti-Rh sera of different specificity and 
therefore suspected the presence of an inhibitor 
• 
0 
substance j.n~.some ·sera. (See Table No. 6). When some 
of their inactive pools were re-examined, they found 
an inhibitor substance present which inhibited anti-Rho 
serum and was therefore of specificity Rho and similar 
to the blocking antibody. Inhibitor substances of 
specificity Rh' and Rh'' were also found in other in'""' 
active pooled sera. Since this inhibitor substance 
was associated with red blood cells, behaved chemically 
similar to any Rh agglutinins, and was found only in 
sensitized Rh individuals, they concluded that it was 
an antibody. 
In addition to the six possible Rh genes 
which determine the eight Rh blood types ( cf. Tables 
5 and i 7 )Race et al. ( 25) proposed two more Rh genes, 
Rhy and Rhx. The latter was later found to be similar 
to Rh2 but the reactions o~ Rhy were not known, only 
' predictej. Nevertheless bloods giving St negative 
. ~ 
and an~i-Rh2 positive reactions were thought to be 
of genotype Rh1 Rhy. One year later Race and Taylor 
(~) found a family in which the mother was Rh1 Rhy 
and the father Rh1 Rh2 and also a donor who was 
Rh1 Rhy~ This was the first evidence that Rhy was 
a~lelomorphic. However in 1945 Murray, Race and 
Taylor (34) encountered this proposed gene in 
I cj. 
Table 6 
Demonstration of Inhibitor Substance by Mixing 2 Types of 
Anti-Rh Sera* 
Degree of Agglutination 
Type of Cell Rh2 Rh1 Rh' rhrh(R~-) 
Control#l: 2 drops of 2% 
cell suspension t one drop 0 ffff ffff 0 
of saline f one drop of 
.Anti ... Rh' serum 
Control#2: 2 drops of 2% 
cell suspension f l·drop ffff fftf 0 0 
of saline f 1 drop of 
Anti-Rho serum 
2 drops of 2% cell 
suspension f 1 drop of 
Anti-Rh' serum f 1 drop 
of Anti~Rh0 serum 
*From Diamond(4?) 
0 tflJ ffff 0 
,f. 
0 
combination with rh and were able to determine its 
reactions. It gave positive reaction's with anti-Rh1 ,_ 
and anti-Rh· sera and a negative reaction with St 
antisera which, according to Fisher's formulation (34), 
were consistent with a gene Rhz. Consequently Rhy 
was really Rhz (See Table No. ? ). 
To make this brief his tory compil.ete ment~,on 
should he made of two antibodies whose identification 
seems somewhat obscure. The patient, type Rh1 Rh1, 
suffering from a dermatological condition received 
numerous transfusions. After the patient received 
transfusions~~rom Rh1 Rh1 , Rh1 r~, and Rh1 Rh1 donors 
Oallendep et al (35) noticed a peculiar antibody inth~ 
recipient's serum which was independent of the A, Bs 
o, M, N, and P factors but not independent of the Rh 
I 
factor. The antigen determined by this anti ... \Afilli~, 
antibopy (named after the first donors name) was 
found to be present in ? per cent of the Rh1 Rh1 
bloods tested. Similarly another peculiar antibody 
was found in the recipient's serum after another transa 
fusion from an Rh1 Rh1 donor named Levay. This weak 
agglutinin, named anti-Levay, was present after four~ 
teen days but the corresponding antigen was only present 
in Levay and his father. 
'~· 
17. 
0 Table 7 
Reactions of Genes Rhj and Rhz* 
Antisera 
r y H A Gene (Anti-Rhl) (St) (Anti-Rh2 ) (.Anti-Rh) 
Rhy I 1-
Rhz 1- 1- 1-
*Adapted from Murray(34) 
0 
0 
DISTRIBUTION OF THE RH FACTORS 
In 1941 Landsteiner and Wiener (19) using 
only anti-Rh sera tested the blood of four hundred 
and forty-eight white individuals and found 84~6 per 
cent to be Rh~ and 15.4 per cent to b~ Rh-. In the 
same year the frequency of Rh~ persons was found to 
be ~9.2 per cent among full-blooded American Indians 
and 95.5 per cent among American Indians of mix~d 
ancestry (36). After the discovery of the various 
Rh subtypes and Rh antisera many human races were 
tested to deter.mine the distribution of the Rh types 
and Rh genes (See Tables 8 and 9 ). It is interest-
ing to note the low incidence of RhA persons in the 
Orientals, Filipinos and Mexican Indians. On this 
basis the incidence of erythroblastosis, for example, 
should be relatively low among these people, and such 
has been observed to be true among the Japanese (37). 
J~. 
0 () 
Table 8 
Distribution of the Rh Blood Types* 
Frequencies of the Rh Types(per cent) 
Population No. persons 
tested tested Rh ... Rh1 Rh2 Rh1Rh2 Rho Rh' Rh" Rh'Rh' t 
Caucas-ians 
(NYC) a. 1000 12.9 54.1 12.8 16.4 2.6 o.9· 0 .. 3 0 
b. 818 13~5 55.6 15.8 12.0 1.'7 1.1 o.-3 0 
c. 2438 14,5 55.6 15,'7 13.1- 2.4 1.1 o.? 0.02 
Caucasians 92'7 14.8 54.9 1'7.2 13.'7 2.5 0.'7 1.3 0 
(England) 
Caucasians 
(Australia) 350 .l4. 9 54.0 12.6 16.5 0.6 0.9 0.5 0 
Negroes (1TYC) 223 163jjoll 20.2 22.4 5.4 41.2 2,'7 0 0 
Asiatic 
Indians 156 '7.1 '70.5 5.1 12.8 1.9 2.6 0 0 
Chinese 132 1.5 60.6 3.0 34.,1 o.s 0 0 0 
Mexican 
Indians 98 0 48.0 9,2 41118 1.0 0 0 0 
Japanese a. 150 1.3 3'7.4 13.,3 4'7.3 0 0 0 o.? 
b. 180 0.6 51.'7 8.3 39.4 0 0 0 0 
Filipinos 100 0 8'7.0 2-.0 11.0 0 0 0 0 
Indonesians 100 0 0 '75 2 : 22 0 -- 0 0 1 
*From Wiener(l} 
-;C> 
,20. 
Table 9 
Frequencies of Rh Genes* 
Series rh Rh1 Rh2 Rho Rh' Rh'' #rs)ested 
Asiatic 
Indians 26.6 56.2 6.0 3.4 4.4 0 156 
Whites 35.9 43.4 13.7 3.5 1~t2 0.4 1000 
Negroes 28.4 11.7 14.4 42.1 2.7 0 223 
Chinese 12.3 64.2 7.9 2.7 0 0 132 
*Moo.ified from Vliener(28) 
HEREDITY OF TBE RH FACTORS 
The Rh factor is inherited as a Mendelian 
dominant while its absence is recessive (38). Also 
Rh1 is dominant over Rh2 (21). Therefore to be Rh~ 
(rhrh) one must have the complete absence of the Rh 
factor in his or her genetic makeup, and this cannot 
occur if one or both parents are homozygous for the 
Rh factor (See ~bles 10 and 11 ). According to 
Hess (39) 43 per cent of all Rhf persons are homozy• 
gous and most fathers of erythroblastotic children 
are also homozygous. 
The Rh blood types are inh1tited by means 
of a series of six allelic genes Rh1, Rh2, Rho, Rh~~ 
Rh'', and rh. These genes show a natural pairing due 
to the special serologic and genetic position of the 
Rho factor in the scheme of the Rh types ( See Table 
No. 12 ) • If only the: reactions wfthl•antt.i~Ra:t::-and 
anti-Rh'' sera are used, four classes are possible 
which are transmitted like the four blood groups by 
triple allelic genes designated U, v. and W similar 
to A, B, and 0 (28) (See Tables 13 and 14). 
I 
Fisher (40) proposes that there are three 
forms of the allelomorphic antigens represented by 
!J.J. 
Table 10 
Genetics of Rh Factor--Illustration 
l D .j. 
RhRh ~rh 
;{ Rh rh 
.., 
Rh RhRh Rhrh 
Children 
Rh RhRh Rhrh 
/ 
Table 11 
Heredity of Rh Factor* 
Father Mother Children 
Homozygous Homozygous All Rh f 
Heterozygous Heterozygous 3 Rhf :t Rh-~ , ~ 
Rete rozygous Rh- i Rhf , .1. Rh ' 2 -
Rh- Rh- All Rh .. 
*Adapted from Wiener(2?) 
- ·-
Table 12 
Scheme of the 8 Rh Blood T.ypes and Four Classes* 
Contain Rho 
Reaction with Antisera 
Lack Rho 
Reactions with Antisera 
Classes Anti-Rh' Anti-Rh" Anti-Rho Type Anti .... Rh' Anti-Rh'' Anti-Rho Types 
w 
-
... 
.;. Rh0 - - ..... Rh ... 
u f ... .;. Rhl f ... ... Rh' 
v .;. f 
(Rh0 '} 
... Rh (Rh~ '') ... f ... Rh'' 
uv .;. f .f Rh Rh (Rric)R§o) .;. 1- .... Rh!\Rh11 
*From Wiener{28) 
•• 
~ 
~ 
Table 13 
Classes of Rh Types* 
Classes Rh Types 
w = Rh"!" .j. Rho 
u .., Rh' .j. Rh1 
..!. 
v .,.. Rh'' f Rh2 
uv = Rh tR~!! 1 t Rh1 Rh2 
*From Wiener(28) 
Tsble 14 
Genes of Rh Classes* 
Class Genes 
w rh t.. Rh0 
u Rh' .;. Rhl 
v Rh'' /- Rh2 
*From Wiener(28) 
0 
0 
o, c, D, d, E, e, and that each gene of the Rh system 
seems to be associated with a· selection of three anti-
gens from these three pairs ( See Table 15 ')J. 
Each of the eight blood types or Phenotypes is 
determined by the combination of two genes (genotype) 
and when the six Rh genes exclusive of Rhy and Rhz 
are considered, there are twenty-one possible genO,~. 
types. Therefore if a person is Rh', his genotype 
may be either Rh' Rh', Rh' rh, etc. (See Table~~). 
If Rhz and Rhy are also included the number of poss-
ible genotypes is markedly increased. 
Table 15 
Antigenic Make-up of Rh Genes-Fisher* 
Antigens Gene 
ODE R?z 
ODe Rhl 
CdE Rh 
Cde Rh:y 
cDE Rh2 
cDe Rh 
cdE Rh9' 
cde Rh-
*Cited by Race{40) 
/ 
PROPERTIES AND REACTIONS OF TEE 
RH. FACTORS; RH GENES; AND RH AGGLUTININS 
Rh Factors and Rh·Genes 
' 
The Rh ~actor is an aggl~tinogen capable 
of stimulating the production of anti-Rh antibodies 
in Rh- persons and also in certain Rhf individuals 
{'·7, 8, 24 ). It is independent of the blood 
groups, M, N, and P factors (5) and is presumed by 
Kouc~y (9) to be a carbohydrate fixed to the proteins 
of red blood cells. That the Rh factor is limited 
only to red blood cells (20) is suggested by the 
fact that it is not present in saliva, sperm cells 
or serminal fluid (13). Wiener et al. (~ suggest 
that this factor may be a subsurface antigen and 
that there are fewer Rh haptens per red' blood cell 
than A, B, and 0 haptens (10). 
The Rh factor is not a single constant 
'10 identity but is rather a mosaic of factors (11,)4) 
and there is an antigenic difference in the Rh 
factors (12). This has been shown to be'true since 
eight Rh subtypes have already been definitely es-
0 
0 
tablished. The reactions of these subtypes are 
shown in Tables 5 and 1q. However, since the genes 
determine the Rh types, it is really the combination 
of genes which determines the reactions of the 
various Rh factors. It is also of interest to ob-
serve that antisera 1 and 4 (42), 3 and 6 and 2 and 
5 give reverse reactions {See Table No. 16 ). 
Wiener et al (45, 46) feel that some weak 
or intermediate reactions of bloods with the Rh anti-
sera are possibly _due to the existence of special 
l 
allelomorphic genes exclusive of the six standard 
allelic genes (not including Rhz or Rhy). {See 
Table No.1? ). The anti-Rh' and anti.-Rh'' sera 
used were really ant~-Rh0 1 and an ti-Rh0 ' t w1 th weak 
anti-Rh0 agglutinins which were eliminated by simple 
dilution. 
Gene Rh0 is the most ant~gen~c, Rh' less, 
and Rh'' the least antigenic. Therefore, individuals 
of types Rh', Rh'', and Rh- are more apt to have 
hemolytic reactions (2?). 
>< 
-Table 16 
__. 
Reactions of 8 Genes to 6 Possible Antisera*** 
Wiener et al. 
Race & Taylor Anti~ooRh1 Anti .... Rh2 AStandard St, ?~r As yet undiscovered Fisher's Notation r H A y ~ s 
Suggested Numbering 1 2 3 4 5 6 
Red Cell Genes 
Rh' Cde' Rh155 (~) .... 1'0 - (:) ( ~) *R~ CDe Rhl26 (f.) ( ... ) (-.) 
Rhz CDE Rhl23 ~ f. ~ ~ '"" o;;l *' *Rh1 CdE Rh135 ... ..,. v} ... Rh'' cDe Rh245 .... ~ "" ~ - .;. Rh2 cDE Rh234 ... ~ ... 
Rho CdE Rh345 ;i't F> f ~ ~ -rh cde Rh456 <;oiJ ... - t 
*Antigenic make""'up of gene R~ should be: OdE • Reactions are only predicted. 
**Antigenic make-up of gene 1 should be CDe 
***From Murray(42) 
) 
-
"!'-
.p 
0 
0 
Table 17 
";rntermediate"Rh Genes* 
Intermediate Type Reactions with Antisera Formerly' Classed 
Rhl(") 
Rh2 { ') 
Rho(") 
Rh(o)' 
Anti-Rh0 Anti-Rh' Anti-Rh" Together with Major [lypes 
J?os. Pos. Weak Rhl'' 
Pos. Weak Pos. Rh2 
Pos. Neg. Weak Rh0 
Weak Pos. Neg. Rh' 
*F.rom Wiener(45) 
Blocking Antibody ( ~ncomplete Antibody, 
Inhibitor Substance, Mature Antibody ) • 
. 
The*inhibitor substance cannot be washed 
orr the red blood cells or dislodged by repeated 
washings, is more stable than th~ corresponding Rh 
antibodies and is rela~ively stable to heating at 
56° c. and to exposure to methiolate solution. Its 
titer is not reduced by dialysis in a collodion 
membrane for twenty-four hours. This substance may 
also become attached to red blood cells both at 
20° c. and at ~4° o. 
Since blocking antibodies-act slower at low 
temperatures, several of the earli~r investigators 
who were testing blood which apparently contained 
blocking antibodies as well as anti-Rh agglutinins 
thought that the anti-Rh antibodies reacted best at 
low temperatures (27). However this has been found 
to be incorrect ( See Table No. 18 ). 
If Rh1 cells are mixed with blocking antiw 
bodies, the blood behaves like Rh' because the Rh0 
site of the Rh1 ( Rhor ) agglutinogen has been blocked. 
Anti-Rh0 blocking antibodies can also convert Rh2 
cells to Rh'', Rh1 Rh2 to Rh' Rh1 ', and Rho to Rh~ (48). 
Table 18 
Thermal Range of Anti-Rh Agglutinins* 
Serum dilution 1:160 
1:80 
1:40 
1:20 
1:10 
, ., 0 
370 200 50 
*From Davidsohn(52) 
I 
) 
' 
)' 
Wiener (1) further postulates that blocking a:q.ti-
bodies are smaller than anti-Rh agglutinins and can 
therefore block the combining sites for anti-Rh 
agglutinins to give a negative clumping rea·ction. . 
Sensitivity 
Natural Rh antibodies or natural sensitivity 
to the Rh facto·r has never been demonstrated in man 
{ 1, 27, 50 ). To become sensitized or to develop 
anti-Rh agglutinins, a person must be exposed to the 
Rh antigen either by a transfusion or by .. pregnancy 
( 6, 50, 51 ); but in spite of exposure to the Rh 
antigen, not every Rh- person becomes sensitized, 
The percentage of sensitization being approximately 
1:25 ( 1, 27, 50 ). There are several factors which 
determine the occurrence of sensitization after ex-
posure to the Rh factor (24)• 
1. Hereditary constitution of the 
patient. 
2. Interval between exposures to the Rh 
factor. Few exposures at wide inte.r-
vals are more effective than a large 
number at short intervals. 
3. Competition of antigens. If a Groupo, 
Rh- mother has a Group A, Rh+ child~ 
the chance of erythroblastosis is less 
than if the child were Group 0 because 
A is a better antigen than Rh. 
~;. 
• 
4. Hormonal factors 
5. Nutritional factors 
Rh+ as well as Rh- individuals may become 
sensitized to the Rh factor, the former being· sensi-
tized by different types of Rh; blood. Thus an 
Rh1 person may be rarely sensitized to the Rh' 1 
factor in blood types Rh2 and Rh1 Rh2 while an Rh2 
person may be sensitized to the Rh'( factor in _blood 
types Rh 1 and Rh1Rh2 ( 24, 2? ). 
Levine ( 53, 54 ) states that once an Rh-
person is sensitized or immunized, this person will 
remain as such throughout life. Even though immed-
iate evidence of isoimmunization is evanescent, the 
reticula endothelial cells are capable of responding 
far more rapidly to the same immunizing stimulus!many 
years later. Therefore, the immune antibodies may' 
be demonstrable for short periods but the immunized 
state is permanent. 
) 
CLINICAL ASPEC'IS OF RH INCON[PATIBILITY 
Hemolytic Anemia of The Newborn 
( Erythroblastosis Fetalis) 
Two years after the discovery of the Rh 
factor Levine and Stetson (55) observed a trans-
fusion reaction in a secundipara female who had 
just delivered a macerated fetus. Her serum showed 
abnormal isoagglutinins which were independ.ent of 
the M, N, and P factors and it was later established 
that she was Rh-, her husband Rh~ and the agglutinins 
anti-Rh. Since this observation many investigators 
qo (,J4, 17, 20, 38, 56, 67, 58, 59, 60, 61 ) have re-
ported similar cases where anti-Rh agglutinins were 
found in Rh- mothers who had delivered Rh; erythro-
. 
blastotic infants. Hemolytic anemia of the newborn 
is also possible when the mother is Rh~ and may then 
be due to isoimmunization of the mother by either 
A, B, M, P, Rh subtypes, or the Hr factors ( s, 27 ). 
Not every pregnancy involving an incompati-
bility bet1Neen the mother's and the child's. blood 
results in the delivery of ~n erythr~blastotic infant 
because, as mentioned before, individuals v~ry in 
their ability to be sensitized (27). Often, too, 
the first Rh4 child of an Rh~ mother is not affected 
because there has not been sufficient stimulus for 
adequate immunization (38). 
nnuring pregnancy anti-immune bodies may 
develop in the mother between the eighth and twelfth 
weekn { 62) 'be1~se the Rh factor in the fetus may be 
present as e~rly as the eleventh week ( 63 ). How-
ever, anti-Rh agglutinins may not always be demonstrable 
in the serum of a mother with an erythroblastotic 
infant (58) unless adequate tests are ~arried out 
since blocking antibodies may be present too (49), 
If these blocking antibodies are present,especially 
with a decreasing titer of anti-Rh agglutinins, the 
prognosis is very poor for the survival of the infant 
{ 1, 39 ). Therefore, it is fitting to do titers of 
the agglutinating antibodies every six weeks for the 
first seven months and every four weeks during the 
last two months because the amount of damage to the 
fetus depends upon the length of its exposure to the 
antibodies (39). 
The titer of anti-Rh antibodies in the mother's 
serum gradually falls following the delivery of an 
erythroblastotic child (52) (See Table No. 19). In a 
C) 
Table 19 
Titers of Anti-Rh Agglutinins Followin~ Delivery 
of a Child with Fetal Erythroblastosis 
Serum Dilution 1:1601 ~~ 
1:80 
1:40 
1:20 
5 10 20 lmo. 
Days 
*From Davidsohn(52) 
·~ 1:80 
1:40 
2mo~t. 4mo$. 6mo$. 
INTERVAL 
() 
15mo$. 
~ 
~ 
series of 141 mothers of erythroblastotic infants 
Levine (64) found that 47 per cent of the mothers 
showed Rh antibodies up to two months po~tpartum~ 
25 per cent up to one year and 5 per cent for one 
year or longer. In another similar case the Rh anti-
bodies persisted for thirty months (9). HOwever, 
the presence of anti-Rh agglutinins in a pregnant 
mother does not necessarily mean an erythroblastotic 
baby, especially if the antibodies can be ascribed 
to a preceeding pregnancy (52). (See Table No. 20). 
The mechanism by which the mother is immun-
ized has not been proved as yet. Levine (14) feels 
that Rh+ fetal blood passes through the placenta 
into the maternal circulation and acts as a foreign 
body to stimulate the pro~uction of anti-Rh agglutinins 
which then pass back through the placenta to hemolyze 
the fetal red blood cells. Wiener (1) goes a step 
~urther to explain how the fetal elements pass the 
placental barrier. He postulates that during labor 
and delivery villi become detached and pass into the 
maternal c~rculation carrying enough fetal red blood 
cells to incite antibody formation. This theory 
helps explain why the firstborn is rarely affected 
unless the mother has been previously sensitized by 
~0· 
~ 
Serum Dilution 
1:60 
1:40 
Table 20 
Anti-Rh Agglutinins Persisting Fo.llowing 
Birth of Infant with Fetal Erythroblastosis* 
~ 
6 wks. 
1!20 
1:10 later 
1:5 
~------------------------------------------------------------------~~ks later 
0 1 2 3 4 5 6 ? 8 9 10 11 12 13 14 15 15 1? 18 19 
Birth of baby 
with erythro-
blastosis. 
*From Davidsohn(52) 
MONTHS P.G. 
?mos. 
Birth of normal 
Rh ... baby. 
:: 
• 
incompatible blood. 
Treatment of erythroblastosis fetalis depends 
on the Rh type of the mother and infant. If the 
infant is Rht and the mother Rh-, Rh- blood should 
be used for transfusions ( 2'7, 38 ,'oo), but if both 
mother and child are Rh• or Rh-, washed maternal 
I 
red blood cells suspended in compatible plasma 
should be administered to the infant (2'7,59). 
Reynolds (64) has a different suggestion which is 
·to give the infant alternating transfusions of Rh41 
and Rh- bloodt the former to neutralize the anti-
bodies and the latter to support the infant. Sinc,e 
anti-Rh agglutinins may be present in the mother's. 
g4j 
milk (~,59 5 65,66), the baby should not be nursed 
as these antibodies may pass through, the intestinal 
canal of the infant and enter the circulation(66). 
Halperin et al. (6'7) studied a series of 
143 erythroblastotic babies and found that 5'7 died 1' 
of which 43 were males and 14 females. Since male 
fetuses are more susceptible than females by a ratio 
of approximately 3:1 it would seem that the females 
have a better chance for survival (6'7). 
Transfusion Reactions 
In 1936 Neter (68) observed an abnormal 
aggluti~in in the serum of a boy who had received three 
transfusions and also that the antigen against which 
this agglutinin was directed was not related to A, B, 
M, N, or P. Since this isoantibody agglutinated ~he 
I 
red cells of the donor (same Group as the boy) and 
also reacted better at ice box temperature, one might 
presume it to be an anti-Rh antibody. Later Wiener 
and Peters (14) encountered three cases of hemolysis 
following the transfusion of,homologous blood which 
were later proved to be due to the rhesus factor. 
Similar cases when Rh+ blood of the various subtypes 
caused a hemolytic reaction in the-Rh- recipient with 
the production of anti-Rh agglutinins have also been 
reported by various investigators (6~~,33,69,70, 71). 
In general transfusion reactions fall into 
two categories (33). 
1. Patients given repeated blood trans-
fusions. The earlier ones serve to 
sensitize them against the Rh an~igen 
while the later transfusions result 
in the hemolysis of the transfused 
red blood cells. 
2. Patients immunized during pregnancy by 
a fetus with incompatible Rh blood. In 
these cases the ·first transfusion re-
sults in a hemolytic reaction. 
I 
A transfusion reaction manifests itself by a varying 
II 
number of symptoms such as chills, fevert decrease 
in hemoglobin level, pain in back, jaundice, hemo~ 
globinuria and anuria (5,6). When any of these are 
present, the transfusion should be stopped immediate-
ly. 
I 
The majority of Rh- people are not sensi~ 
tized to the Rh factor despite repeated transfusions 
of Rh+, blood, the incidence being about 1:25-50 {27). 
There are, in addition, a few Rhf individuals who 
may be sensitized against the M, N, o, A and Hr 
factors and also against the various Rh subtypes(24,27). 
Blocking antibodies may also be present in a sensi-
. 
tized person and take part in a transfusion reaction 
when incom~atible Rh blooq is given. Wben these are 
'I 
present adequate tests should be carried out to deter-
. . 
mine their presence because their titer may be hi~h 
enough to block the anti-Rh agglutinins in the ordin-
ary cross matching test (24). Therefore the cross 
matching test is not reliable enough when testing for 
sensitivity due to the Rh factor. 
Sensi ti vi ty to the Rh factor takes at least 
five to seven days to develop following a transfusion 
of incompatible blood. Therefore if such transfusions 
are given rapidly enough with intervals of less than 
three to five days, the person will not have the 
opportunity to become sensitized (27,50). HoweveF, 
all individuals should be typed as to their Rh 
phenotype and genotype, if possible, and compatible 
blood given when transfusions are necessary. That 
accuracy is required is illustrated by the case of 
an Rh- patient who received so many transfusions 
from Rhf donors that her blood type was thought to 
be Rhf due to the large number of donor's red cells 
still in her circulation(72). 
Abortions and Miscarriages 
van Dorsser et al. (73) studied the number 
of abortions and miscarriages in Rh~ and Rh- women 
and found an incidence of 23 per cent in the former 
and 27 per cent in the latter. Also 35 per cent 
or 89 of 412 pregnancies in Rh; women ended unfavor-
ably while 50 per cent or 47 of 94 pregnancies in 
Rh- women ended similarly. From these statistics 
van Dorsser et al. (73) concluded that an Rh- woman 
is not particularly more apt to lose her child 
either before or during birth or in the neonatal 
period of her first, second, or third pregnancies 
than is ~ Rhf woman. Hunt (74) and Schwartz et 
al. (75) also concluded that the Rh factor is not 
very important in the etiology of early abortions 1 
or miscarriages as the Rh factor apparently comes 
into play only in the latter hal~ of the gestation 
period. 
Mental Deficiency and Feeblemindedness 
The proportion of Rhf children from Rh~ 
'mothers should be approximately 8% (76). Snyder 
et al. (76) tested 68 feebleminded children from 
Rh- mothers and foUnd 11 to be Rh~ or 16.4 per cent 
which is an increase over the normal expected number. 
They also tested 66 mothers of feebleminded childr~n 
and found 17 to be Rh- or 25.5 per cent when the 
normal percentage of Rh- people in the population is 
approximately 13 per cent. From these studies they 
decided that there was an increased incidence of ~­
mothers among the mothers of feebleminded children" 
and also of feebleminded Rhi children.from Rh-
mothers. Yanett and Lieberman (77) found similar 
percentages i. e. 19% Rh~ children from Rh- mothers 
and 25 % Rh- mothers of feebleminded children. They 
suggest the possibility that Rh iso~unization may 
~ve some etiological significance in a certain pro-
portion of these cases.. 
Medicolegal Application 
The Rh fact~IDs are important in disputed' 
paternity cases; and when the following facts are 
considered, the chances of exclusion are raised to 
approximately 45% (48). 
1. Properties of Rh0 , Rh' and Rh'' ca4~ 
not be in,the child unless in one or 
both parents. 
2. Class W parent cannot have a class 
UV child and a class UV parent cannot 
have a class W child. 
t./7. 
0 
0 
TESTS FOR TEE RH FACTORS AND RH SENSITIZATION
11 
Anti-Rh Testing Sera 
There are three sources of anti-Rh sera (52). 
First, hetero-immune serum may be produced by treating 
guinea pigs with rhesus blood. _.Landsteiner (19) and 
Carter {78) have used this sera and obtained good re-
sults, but such sera is really difficult to produ~e, 
must be purified and will, ·in some cases, clump the 
Rh- red blood cells of newborn infants (52). Second~ 
anti-Rh sera can be secured from Rh- persons who have 
received transfusions of Rh+ blood, but people with 
a high enough titer .are rare. Hill and co-workers (79) 
suggest the intravenous ihjection of Rhf cells into 
individuals previously sensitized to the Rh factor 
either by pregnancies or transfusions. Diamond (91) 
injected Rh- students with small amounts of Rhf blood 
" 
and was able to stimulate the production of anti-Rh 
agglutinins • When the titer of these agglutinins 
became high enough, the sera could be used for testing 
other bloods for the Rh factor. However, in these 
students repeated stimulation called forth the pro-
duction of blocking antibodies which apparently made 
the sera useless for testing purposes. Third, anti-
Rh sera may be obtained from Rh- mothers of children 
I 
with hemolytic anemia of the newborn. This has been 
a good but limited source and the best time to obtain 
these agglutinins is 8-20 days po'stpartum (48). A 
fourth source shoul~ be added and that is the anti-Rh 
sera produced by injecting rhesus red cells into 
~h 
rabbits (81). However, the,\ agglutinins in rabbit sera 
are not identical to the ones in human sera. 
Opinion is divided as to which of the above 
sources is the best. Wiener (27,48) feels that anti-
Rhesus sera is better than human sera because the 
latter's specificity must be determined i.e. Anti-Rh0~ 
anti-Rh', Anti-Rh'', anti-Rh0 ', and anti-Rh0 ''· 
I' 
In 
addition there may be alpha or beta agglutinins in the 
human sera which have to be removed. They can be ab-
sorbed by their appropriate cells or inhibited by a 
polysaccharide isolated from pig roundworms by de 
Torregrosa (80). On the other hand, De Gowin (51) 
thinks that human se~um is the best ~· 
Blocking antibodies can play a useful role 
in the production of anti-Rh sera. If o, Rh 1 and Rh2 
I bloods are treated with blocking antibodies, they be-
come 0, Rh' and Rh''· Serum run against these four 
I 
types can thereby be typed. Blocking antibodes are 
also capable of converting anti-Rh0 ' and anti-Rh0 '~ 
sera into anti-Rh' and anti-Rh'' sera thus making 
four anti-Rh sera from two (48'). 
Rh Factors 
At least three anti-Rh sera are necessary'' 
,, 
to test fo:+ the Rh factors (12) (See Table No. 5 )'~ 
and with the additional use of anti-Hr sera, a 
certain nu~ber of Rh genotypes can be determined 
(See Table No~1~). 
Rh Sensitization 
In general there are five difficulties 
encounte_red when testing for Rh incompatibility (51). 
1. Lack of Rh typing sera 
2. Lack of adequat~ methods for demonstra~ 
tion of anti-Rh agglutinins in the 
laboratory. 
3. The use of weak anti-Rh agglutini,ns · 
making it difficult to determine the 
presence of sufficient agglutination 
if present. This is especially t'rue 
when stored blood is used because 
during storage, sedime~t forms which 
requires slight shaking. This will 
break up anti-Rh agglutination. 
fo. 
I 
4. Differentiation between rouleaux forma-
tion and true agglutination. Again this 
is important when preserved blood is used 
because red blood cells lose their bi~ 
concavity.so rouleaux formation is similar· 
to agglutination. 
5. Time of incubation of cell-serum suspen-
sion. Thirty to sixty minutes are necess-
ary to demonstrate anti-Rh ·agglutinatipn, 
and this is too long in the presence of an 
emergency. 
However, some of these difficulties have been either 
alleviated or eliminated by the recent discovery of 
a few new tests to be described-below. 
BioloGic Test (82) 
Method 
1. Inject 50 c.c. of Rhf cells into Rh-
patient suspected of having Rh antibodies. 
2. Draw sample of plasma and serum prior to 
injection and compare with samples take~ 
one hour after injection. Any change in 
depth of color of the pil..asma or se'rum 
shows that the blood injected is incom-
patible. ' 
Disadvantages 
1. Necessity of making many venipunctures. 
2. May give immediate ·transfusion reaction • 
. 3. May initiate or restimulate antibody pro- .. 
duction (53) . 
Advantage 
1. None now that other tests are available. 
Modified Compatibility or Tube Incubation Test (52,82) 
Method 
1. Add 2 drops of questionable serum to 2 drops 
of a 2% suspension of Group 0, Rh+ red cells 
in normal saline. 
2. Shake and incubate for one hour at 370 u. 
51-
3. Agitate and centrifuge at 500 r.p.m. 
4. Note contour of plug. :A smooth outline 
is characteristic of a negative test. 
5. Gently loosen the sediment by tilting 
tube and exam macroscopically and micro:-
scopicall~ if necessary for clumping (See 
Table No. 21) 
6. Run a Rh- control. 
The Rh agglutinins are modified globulins 
and probably b.ivalent so each antibody molecule has 
one specific compining group for the corresponding 
Rh hapten. Therefore in agglutination a latticework 
framework results (1). 
Rh pes. rbc ~ bivalent Rh antibodies~ (agglutinins) rt. 
~ agglutination (~) (See Table No~22) 
Disadvantages 
1. Inexperienced person may agitate the se'di-
., ment too much and brea.k up the clump. 
2. Clumping may be .mistaken or not seen at 
all by inexperienced person. 
Advantages 
1. M.D. can follow development of anti·bodies 
and thus have an idea of the prognosis. 
2. 'If these antibodies increase in strengt~ 
in last few months only, the fetus has a 
fair chance. 
After the material has been spun down 
(ste.p j), Diamond and Denton (86) suggest replacing 
the supernatant saline vdth 20% albumin because any 
I 
Rh antibodies present will be seen to agglutinate 
at room temperature within a few minutes. 
f2.. 
0 
0 
Table 21 
Sedimentative Method of 
Testing for the Rh Factor* 
Figure 1 Figure 2 
Figure 3 Figure· 4 
Fig. 1 --Negative reaction 
Fig. 2 --Faintly positive reaction 
Fig. 3 -QWeak reaction 
Fig. 4 --Typical positive reaction 
*From Wiener(48) 
Table 22 
Concept of Agglutination* 
0 
\Rh antigen Anti-Rh 
Agglutinin 
*From Wiener(48} 
Agglutination 
0 
Blocking Test (30,82) · 
Method 
1. Add 1 drop of patient's· serum to 1 drop 
of 2% suspension-of Rht cells and mix. 
The Rhf cells should belong to Rh1 or 
Rh2 phenotypes. . 
2. Incubate for 30-60 minutes at 380 c. ~n 
water bath. 
3. Centrifuge 
4. Add 1 drop of potent (active) anti-Rh0 
serum. Rh' or Rho'' antiserum shoulu, 
not be use8 as the Rh' and Rh' ' agglutinins 
will interfere with Rh1 and Rh2 cells 
respectively. 
5. Incubate 30-60 minutes and centrifuge., 
6. Note-If blocking antibodies are present, 
no agglutination will occur or the clum~ing 
will be markedly weakened (See Table 23). · 
7. Run control. 
This reaction is specific because the 
reaction has been obtained up to June 1944 only from 
Rh- individuals sensitive to the Rh factor, and not 
with sera from Rhf or normal Rh- people not sensitized· 
to the Rh factor (30). 
Combined Tube Incubation Test for A lutination and 
Blocking ntibodies 82 
Method 
1. Set up tube incubation test. 
2. In addition set up two additional suspen-
sions of Rh+ cells, one suspension belong-
ing to Rh0 1 and the other to Rh0 '' pheno-
types. 
3. Add 2 drops of the patient's serum and the 
" potent agglutinating serum. 
4. Incubate and centrifuge. 
5. Note-If agglutination occurs in contr9l but 
is absent or inhibited in the other tubes 
of patient's serum, blocking antibodies are 
present. 
6. Run control. 
Table 23 
Concept of Blocking* 
Anti-Rh 
Blocking 
Antibody 
*From Wiener(48) 
Blocking" 
Capillary Tube Test (82) 
Method 
1. Sterilize tubes of 0.4 mm. bore and 8 em. 
long. 
2. Di.p one end in patient's serum and a:llow 
serum to run up to 2 em. mark. 
3. Then dip into fresh Group 0 blood, oxalated 
or citrated. Don't allow any air bubbl,es 
to enter. 
4. Invert tubes and insert in a rack (45° angle) 
Incubate at 37.5 oo. 
5. Read agains·t a white background. If pos'itive, 
there will be a beaded layer along the low-
er side of the capillary. If negative," there 
will be only a smooth t·hin line. 
Test for Race's "Incomplete Antibody" (83) 
This test is based on the idea that such 
sensitized red blood cells have adsorbed antibody 
globulin, and anti-human globulin serum might detect 
such cases. 
Method 
1. Add 2 drops of 2% suspension of washed rbc 
of an appropriate Rh genotype to equal vol-
ume of patient·' s serum. '1 
2. Incubate at 370 for i hour. 
3. Examine for agglutination. Rh agglutinins 
will show up here if they are not too weak. 
Failure of agglutination means (1) compat-
ible blood, or (2) presence of ''incomplete 
antibody). 
4. Wash deposited cells with saline thoroughly 
to remove any human serum. 
5. Add to these washed cells an equal volume 
of an appropriate dilution of rabbit anti-
human globulin serpm which has all aggl~t­
inins to human red blood cells absorbed 
from it. 
6. Incubate for t hour. 
7. Examine for agglutination both micro- and 
macroscopically. 
51. 
0 
1 
,_/ 
Slide Test (84) 
Method 
1. 0 .2· c. c. fresh, oxala ted Rh-, Rh1 and Rh2 Group 0 whole blood or washed cells (4dw 
50% suspension) are placed on a slide. 
2. Mix 0.1 c.c. of.patient's sera or sera to 
be tested with each. 
3. Rotate and mix the mixture. 
4. Warm to 37° c. or room temperature and read 
over a ground glass plate with 40 watt bulb 
underneath. 
5. Agglutination will occur in 1-3 min. if the 
serum was from a person sensitized to the 
Rh factor. 
6. Run a control. ' 
7. Add saline to' break up rouleaux if present. 
Eostulated Mechanism of test - Inhibitor sub-
stance and agglutinins exist independently in 
most sera. When the inhibitor substance 
(blocking antibody) is present in nearly equi-
valent or stronge_r titer than the agglutinin 
or a thin suspension is used, the inhibitor 
substance binds m6st of the red blood cells 
so few cells are' left to be agglutinated by 
the anti-Rh agglu.tinins. If large numbers of 
red blood cells are used (40-50% suspension) 
enoug~ red b~ood cells will be present to 
absorb the inhibitor sugstance and also com-
bine with the agglutinin to give clumping· (84). 
Conglutination Test (1,85) · 
This test depends on the sensitization of the Rhf ' 
cells by their specific antibody and the presence 
of a thermostable colloidal substance in the serum 
or plasma ( x-protein). · 
Method , 
1. Add serum to be tested undiluted or diluted 
with plasma or compatible serum to a 2% 
blood suspension diluted with plasma or 
serum and not saline. 
2. Strong clumping will occur in the presence 
of anti-Rh agglutinins and/or blocking anti-
bodies. 
This test gives a positive reaction when 
there are Rh antibodies present but undetected by the 
I 
agglutination or blocking te~ts. Since a third com-
ponent, identical with the X pro·tein, is necessary, 
this conglutination test occurs in two stages (1). 
Rh pos. rbc + ( univalent Rh antibodies ) + 
( Lblockers or agglutinini!) 
( conglutinin) ~ conglutination ( a protei!J) 
The X protein is not a complement be-
cause it will not cause clumping unless the cells 
have been previously sensitized and will still cause 
clumping after being heated to 60° C. for 30 minut~s. 
Furthermore, it dissociates when the plasma is diluted 
,, 
with water or saline so do not dilute the red cells 
or the serum with saline. This X protein possibly 
does not form until after birth, a fact which might 
explain why some infants do not show erythroblastosis 
fetalis until sevexal hours or days after birth. (1) 
The Rh antibody participating in this,, 
conglutination reaction is called a glutinin ( may
1 I 
or may not be identical with the blocking antibody) 
which is univalent and therefore probably plays a more 
impo~tant xole in erythroblastosis fetalis than the 
anti-Rh agglutinin (1). 
{9. 
I 
DETE~iiNATION OF TEE SPECIFICITY 
AND TITER OF TEE BLOCKTI\fG ANTIBODY 
In 1945 Diamond and Denton(86) found 
that plasma provided a medium in which blocking 
antibodies could agglutinate and that dilution or 
absence of plasma resulted in blocking but no clump-
, 
ing. Saline, plasma, human albumin (25% ), bqvin~ 
albumin ( 30%), gelatine, methyl cellulose, dextr·ose, 
and polyvinyl alcohol were tried as diluents, but 
the best reactions were obtained with plasma and 
alb~~· Since bovana albumin was cheaper and mor~ 
readily obtainable, they considered it the best. 
In addition it showed more rapid reactio~s at 3? 0 c. 
and at room temperature than plasma. The 30% bovine 
albumin gave a stronger reaction with Group o, Rh~ 
cells (washed) in reference to the blocking antibo'dy 
while 10% gave fff reaction with Group 0, Rh2 cells 
and none with Rh1 cells. No reactions were demons~ra­
ted with Rh- cells regardles·s of the concentration 
of albumin used. Therefore, for all practical pur..-
poses a 2o% concentration of bovine albumin gives 
' 
uniformly good reactions. 
Using plasma and saline together Diamond 
' 
and Denton(86) were able to determine the titer of. 
0 
) 
the blocking antibody present. The total antibody 
titer was 1:512 and the ordinary agglutinin titer 
1:8. Therefore the titer of the blocking antibody 
,, 
is the difference between these two titers ( 1:512 
and 1:8 ) ( See Table No. 24 ) • 
Similarly they were able to determin~ 
the specificity of the blocking antibody present.· 
Since agglutination of Rh1 and Rh' cells occurred,, 
the agglutinin was of type anti-Rh'. Likewise, 
since agglutination occurred with Rh2 cells in 
albumin and not in saline, the blocking antibody 
was of specificity anti-Rh0 (86) (See Table No. 25 ). 
Ql 
Table 24 
Titration of Anti~Rh Blocking-Agglutinin Antibody in Saline 
and in Plasma Media (Washed test cells,, Group 0,, Rh1 ; Antibody--Agglutinin, Anti-Rh'; and Blocking 
Anti-Rh0 )""' 
Serum Dilution 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 
2%cells in 
saline {serum 
diluted with tf lit tf trace 0 0 0 0 0 0 
saline} 
2% cells in 
plasma(serum solid solid solid solid ttft ttt ftf tt f trace diluted with 
plasma) 
*Frbm Diammnd{86) -
a 
1:1024 
0 
0 
("'-
~ 
0 
-
0 
Table 25 
Determination of the Specificity of the Rh Antibody 
(Blocking and Agglutinin) by the Reaction of 
2% cells 
saline 
2% cells 
albumin 
Test Cells Suspended in Saline and Albumin. 
(Antibody-Agglutinin, Anti-Rh'; and 
Blocking, Anti-Rh0 )* 
Rh1 Rh2 Rh' Rh-
in 
ttff 0 ffl-f. 0 
in 
solid 'tfl-f solid 0 
*From Diamond(86~ 
) 
THE HR FACTORS 
INTRODUCTION 
There seems to be a distinct relation-
ship between the Hr genes and the Rh genes ( See 
Table No. 26 ). Since every gene negative for Rh' 
is positive for Hr, Rh' and Hr are related to each 
other both serologically and genetically, similar 
to M and N (1). Therefore, it is necessary to dis'.:.. 
cuss briefly this factor (Hr), the reactions it deter-
mines and its clinical importance. 
0 
Hr Genotype 
HrHr 
Hrhr 
hrhr 
Table 26 
The Hr Types and Genotypes in Relation to 
the Rh Types and Genotypes* 
Reaction with 
Anti-Hr Serum 
Strong 
Medium or Weak 
Negative 
Rh Genotypes 
rhrh, Rh0 rh, Rh0 RhQ Rh rh, Rh Rh , Rh2Hh Rh22Rh" R2nRR Rh'•rB. 
' ll ' ~ Rh"Rhu. 0 
Rh1rh, Rh1Rh~t Rh'Rh0 ~ Rh' rh,, Rhl Rh '• Rh tRh2, Rh1Rh2, Rn'Rh", 
Rh1Rh11 Rh1Rh'~ Rh'Rh'• 
*From Wiene,r{48) 
0 
Rh Types 
Rh-, Rh0 , Rh2, Rh". 
Rh1, Rh', RhJ.Rh2 , Rh 'Rh'". 
Rh1 and Rh' 
II" 
~' 
0 
0 
HISTORY OF THE HR FACTORS AND HR AGGLUTINJNS 
The Hr factor was discovered by Levine 
et al.(20) in 1941. They found an atypical agglu~inin 
in the serum of a patient which gave strong_ reactions 
almost exclusively with bloods previously typed as 
Rh-. Since this agglutinin was_related in some way 
to the Rh factor, it was designated as anti-Hr and 
the blood factor determined by it as Hr (3,90). 
Race and Taylor (32) found an anti serum 
(ST) which ·was similar to the anti-Hr serum discovered 
by Levine et al (20). However, Levine's serum failed 
to react with 50% of the people while the ST serum 
failed in only 20% of the population. Later a stronger 
I 
anti-Hr was tested and reacted with 60% of the Rh1 
, 
bloods but not with Rh1 Rh2 blood whereas ST reacted 
with all the Rh1 Rh2 bloods (44). Therefore Race ~t 
al. (44) decided that ST and Hr antiserum were not the 
same. They further concluded that Levine's powerful 
anti-Hr serum seemed to be the predicted ~ serum of 
Fisher and Wiener's anti-Hr to be the same as ST of Y 
serum. On the other hand, Wiener (43) believes' 
that Levine's anti-Hr serum really conforms to the 
standard anti*Kr serum and not to the S serum. 
'• 
0 
0 
Before proceeding further it seems 
necessary to correlate Fisher's terminology (40) 
with Wiener's classification of anti-Hr serum (43). 
Fisher (40) proposed that there are three different 
antisera which are capable of agglutinating Rh- blood. 
corresponding to the three types of a~ti-Rh sera. 
These anti sera of~ Fisher are designated as Hr 
antisera by Wiener {43). Since the standard anti~ 
Hr serum is related to anti-Rh', it is called anti-
Hr'. Likewi13e, the other two antisera postulated 1'by 
Fisher (40) are related to anti~Rh'' and anti-Rh0 
and. are therefore called anti-Hr'' and anti-Hr0 (43). 
Accordingly, the blood factors determined by these 
three Hr antisera are Hr', Hr'', and Hr0 • When 
Tables 27 and 16 are com,Pared, it is evident that , 
antisera ST ::: anti-Hr' :: y , anti-Hr'' :: ~ ., a~d 
anti-Hr0 = S • 
In 1945 Mourant (87) observed a Group 0 
patient who had received numerous Group 0 transfusions 
and whose serum contained an antibody which failed to 
agglutinate 4.1% of 662 Group 0 donors and other bloods 
selected without respect to the Rh factor. Seven of 
eight individuals whose blood failed to react with this 
new antibody were Rh2 Rh2 and Rh2 rh. The eighth was · 
0 Table 27 
The. Rh Series of Allelic Genes* 
Reactions with Rh Reactions with Hr 
Genes Antisera Antisera 
Rht Rh" Rh0 {standard) Hr' (standard J Hr" {Hr0 ) 
rh 
- "" ~ ~ (f) Rhlfl - .;. (-) Rh ~ .... ... ~ (,l) :* ... .J. - ( .... ) - ~· .... f. - (f) -;I Rh2 .... f {:) .... ( ... ) (Rhy) (~) '{'f) {!-) ~8) (,l) Rhz t .;, ... ( ... ) 
Gene and reactions in narentheses 
~edified from Wiener(43) are only predicted 
0 
0 
b 
type Rht rhorRh"' Rh''· He concluded that-this· 
serum corresponded to Fisher's ~ because, as pre-
dicted by Fisher (42), it reacted with only cells 
of Rh genotypes containing the genes Rh1, Rh', Rh0 
and rh and not those comppsed exclusively of Rh2~ 
Rh'', and Rhz and the undetermined Rhy genes, Wiener 
{43) also agrees to this conclusion. 
DISTRIBUTION OF THE HR FACTOR 
I 
The distribution of the Hr factor in sev~,ral 
of the huma.n races is shown in Table No. 28 {43). 
HEREDITY OF TEE HR FACTORS 
The three possible Hr factors in the red 
blood cells reacting with anti-Hrt, anti-Hr''; and 
anti-Hr0 are inherited as Mendelian dominants. For 
example, the Hr' factor may be considered as inherited 
by a pair of allelic genes Hr 1 and hr1 similar to the 
Rh+ factor ( Rh' and rh' ). As is shown in Table No. 
'I 
27~ the genes reacting with antiQF~' serum are rh~ 
(, '/. 
0 
0 
Table 28 
Distribution of the Hr Factor in Various Races* 
Population 
Whites 
Negroes 
Mexican 
Indians 
*Modified 
No. of Persons 
Tested 
239 
350 
49 
98 
from Wiener(43) 
Percentage of ~ositive 
Reactions 
Observed Expected 
72.0 so.o 
so.o so .. o 
98.,0 97.7 
55.8 53.8 
'/o. 
0 
Rho. Rht' and Rh2 while those not reacting are 
Rh', Rh1 , Rhy and Rhz. The Rh genes reacting with 
anti-Rh' serum are Rh'~ Rh1 , Rhy and Rhz while those 
not reacting are rh, Rh0 , Rh't, and Rh2 • Therefore. 
collective genes Hr' and hr' are identical with 
collective genes rh' and Rh' respectively (43). Also 
according to Wiener's theory of inheritance, gene, 
q~w'-Hr would be equal to class W and V and g~ve hr to 
class U (48). 
REACTIONS OF THE ER Al\fTISERA 
illable No.29 shows the reactions of the 
Rh genotypes with anti-Hr sera and also the relation 
,, 
of the Hr factor to the Rh blood types or phenotyp~s. 
The reactions with anti-Hr ~~~ are important, 
especially in determining the various genotypes of' 
,, 
the Rh phenotypes. 
'! {. 
0 a 
Table 29 
Relation of the Hr Factor to the Rh Blood Types* 
. ' . 
. 
Rh Blood Type Reactions with Rh Genotypes ·Reactions with Hr 
Antisera Antisera 
Anti-Rh' Anti-Rhtt ·Anti-Rh0 Anti-Hr• Anti-Hr" Anti-Hr dprediMt'ed) 
Rh ... ... liii> .... rhrh strong strong strong 
Rh' .;. ... .... Rh'·Rh' neg • strong strong 
Rhtrh weak strong strong 
Rh" ... ~ R Rh"Rh't strong neg. strong 
Rh''rh strong weak strong 
Rh 'Rh" .;. f 
-
· Rh'Rh" weak weak strong 
Rho .,. .... .;. Rh0 Rh0 strong strdmg neg,. Rh0 rh strong strong weak Rh1 ,f ~ .;. Rh1Rh1 neg. strong neg~ 
RhlRh~' negir strong weak 
Rh1rh weak strong weak 
RhtRh0 weak strong neg. Rh Rh weak strong weak 
Rh2 ~ ~ .;. Rh2Rh~ strong neg. neg. 
Rh2Rh'' strong neg. weak 
Rh2rh strong weak weak 
Rh2Rho strong weak neg a 
Rh"Rh strong weak weak 0. Rh1Fh2 .f .;. f Rh1Rh2 = weak weak neg. 
Rh1Rh" wealr weak weak 
Rh'Rh2 weak weak weak 
* 
Rh1Rhz neg. weak neg. 
~-w..,..a_L-e_-fod ·end ~da}!ltecl f~l=} 
II 
-..:1 
~ 
• 
0 
0 
CLINICAL IMJ?ORTANCE OF TEE Iffi FACTOR AND HR ~.NTIS~BA 
Erythroblasto?is Fetalis and Transfusion Re~ctions 
An Hr negative person may be sensitized 
!' 
to the Hr factor (88) either by a pregnancy or a 
transfusion or both. This is irrespective of the 
Rh factor because a person can be either Hr+ or Hr-
-
and still be Rhf while an Rh- person is always Hr~ 
and homozygous for the Hr factor ( See Table No. 26}. 
Therefore, Hr sensitization should be considered 
when an Rh·F.mother delivers an erythroblastotic baby 
or when an Rhf ~erson suffers a· transfusion reaction 
-with blood from an Rht donor (46). Infants with 
hemolytic disease of the newborn due to Hr incompa,iti-
bility should be transfused with washed red cells of 
the mother suspended in compatible plasma (46) and 
should not be nursed because the Hr antibodies may 
" 
also be in the mother's milk (88). 
Importance of Hr Antisera 
Hr antisera ( anti-Hr' and anti-Hr'' ) 
are essential for the differentiation of the various 
Rh genotypes (46; 8?, 88). (See Table No. 29 ). 
0· 
I b 
However, even with these two anti-Hr sera, not all 
genotypes are differentiable. 
Medicolegal Aspect 
In disputed paternity cases, the chances 
of proving innocence are better than 50% when tests 
for the A-B-0 blood groups, subgroups of A, M-N types, 
I 
Rh types and standard Hr factor are performed. Ttle 
chances of exclusion will be raised even higher w~en 
anti-Hr'' serum is available and anti-Hr0 serum is. 
discovered and available. Such exclusions would be 
based on the following facts (43). 
1. "Factq:rs Rh', Rh'', Rh0 , Hr' ', Hr', atJ.d Hr9 cannot appear in the blood of a ch~ld unless present in the blood of 
one or both parents." (43) 
2. "Parents with blood lacking a particular 
Rh factor cannot have children with 
blood lacking the corresponding Hr factor; 
and parents lacking any of the Hr factors 
cannot have children lacking the corres-
ponding Rh factors." (43) 
SUMMARY 
~lthough this paper has been an attempted re-
view of the Rh and Hr factors, several important facts 
will be summarized below. 
i. The R~ and Hr genes appear to be related. 
2. The Rh and Hr factors are antigenic and are capable of 
stimulating the production of anti-Rh agglutinins, 
blocking antibodies and anti-Hr agglutinins. 
3. Excluding the pre.dicted Hr0 and Rhy, there are ? ,known 
Rh genes and 2 Hr genes. 
4. Excluding genes Rhz and Rhy, there are 21 Rh genotypes 
represented by 8 Rh phenotypes or types of which ? are 
Rh+ and 1 Rh-. ~pproximately 15% of the population is 
Rh-. ' 
5. If the Rh genotype or in some cases the Rh type is 
known, the presence or absence of the Hr factor is 
likewise known. 
6. Not every Rh- person becomes sensitized to the Rh 
factor even though exposed through an incompatible 
transfusion or pregnancy. A Rh+ person may also be. 
sensitized to a different Rh+ subtype. 1 
?. Most of the cases of erythroblastosis fetalis (hemo-
lytic anemia of the newborn) are due to Rh incompati-
bility, while a few are due to incompatibility to the 
Hr and other blood factors. 
8. If a person with anti-Rh or blocking antibodies is 
transfused with incompatible Rh blood, a transfusion 
reaction will result. Transfusion reactions may also 
occur among Rh+ persons due to Hr incompatibility. 
9. The Rh factor does not appear to be the cause of early 
abortions or miscarriages but may be of significance 
in the incidence of feeblemindedness. 
10. Both the Rh and Hr factors are very important in ~stab­
lishing paternity when used in conjunction with the 
J:>lood groups and 1[--N factors. 
CONCLUSIONS 
<:) 1. The Hr factors are important in clinical medicine, but 
the Rh factors are more important. 
2. Every person should be typed for the Rh factor and the 
genotype determined if possible. 
3. Tests for both anti-Rh agglutinins and blocking anti-
bodies should be carried out when there is a question 
of Rh sensitization. 
0 
() 
BIBLIOGRAPHY 
1. Wiener, A. S.: Rh Factors in Clinical Medicine, 
de Lab. & Clin. Med. 30:957 (Nov.) 1945. 
2. Boyd, w. C.: Fundamentals of Immunology, New York, 
Interscience Publishers Inc., 1943, p. 158. 
I 
3. Karsner, H. T., and Hooker, s. B.: Yearbook of 
Pathology and Immunology, Chicago, The Year Book 
Publishers Inc., 1941, p. 509. 
4. Landsteiner, K., and Wiener, A. S.: An Agglutinable 
Factor in Human Blood Recognized by Immune Sera for 
Rhesus Blood, Proc. Soc. Exper. Biol. & Med. 43:223 
{dan.) 1940. 
5.· Diamond, L. K.: The Clinical Importance of the Rh 
Blood Type, New England d. Med. 232:4~7, 475 (Apr.} 1945. 
5. Hammack, R. w. :· Rh Factor in Intra-group Hemolytic 
Transfusion Reactions, California & West. Med. 51:135 (Sept.) 1944. 
7. Waller, R. K., Levine, P., and Garrow, I.: A Case of 
Erythroblastosis Caused by Immuni~ation of an Rh 
Positive Mother by the Rh Factor, Am. J. Clin. Path. 
14:577 (Nov.) 1944. 
8. Levine, P.; On the Hr Factor and the Rh Genetic T.heory, 
Science 102:1 (July 5) 1945. 
9. Wiener, A. s., Sonn, E. B., and Belkin, R. B.: Th,e 
Nature of Agglutination Reactions, Science 100:98 
(Aug.) 1944. 
10. Belkin, R. B., and Wiener, A. S.: Demonstration of the 
Properties A, B, M; N, and Rh in Red Cell Stromata, 
Proc. Soc. Exper. Biol. & Med. 55:214 (June) 1944.' 
11. Potter, E. L.,'Davidsohn, Jr., and Grunden, A. B.: The 
Importance of the Rh Blood Factor fn Erythroblastos~s, 
Am. J. Obst. & Gynec. 45: 254 (Feb.) 1943. 
12. Davidsohn, I., and Toharsky, B.: The Rh Blood Factor; 
An Antigenic Analysis, Am. J. Clin. Path. 12:434 (Aug.) 
1942. 
13. Levine, P., and Katzin, E. M.: Pathogenesis of Erythro-
blastosis: Absence of the Rh Factor fromSaliva, Proc • 
.-. "rn T"> o ~~1'"'~=f(~t=r:F....1~.C\.~-J~L-1~=======1:1===== -~- I ·• 
' -,.: ~ !: 
\<~~ ~' 
14. Wiener, A. s., and Peters, H. R.: Hemolytic Reactions 
Following Transfusions of ~lood of the Homologo~s Group, 
with 3 Cases in which the Same Agglutinog~n Was Res-
ponsible, Am~.Int. ~ed. 13~2306 (March 11) 1940. 
15. Levine, P.; and Kat~in, E. M.: Isoimmunization in 
Pregnancy and the Varietie·s- of Isoagglutinins Observed, 
Proc. Soc. Exper. Biol. & Med. 45: 343 (Oct.) 1940. 
16. Levine, P., Katzin, E. M., and Burnham, L.: Atypical 
Warm Isoagglutinins, Proc. Soc. Exper. Biol. & Med. 
45;346 (Oct.) 1940. 
17. 
18. 
Levine, P., Katzin, 
ation in Pregnancy: 
of Erythroblastosis 
1941. 
E. M., and Burnham, L.: Isoimmuniz-
Its Possible Bearing on the Etiology 
Foetalis, J. A.M. A. 116:825 (Mar.l) 
Wiener, A. S.: I .• Hemolytic 
II. Prevention, with Special 
Cross-matching Tests, Am. J. 
1942. 
" Transfusion Reedtions. 
Reference to the Rh and 
Olin. Path. 12;302 (June} 
'. 
19. Landsteiner, K., and Wiener, A. s.: Studies on an 
Agglutinogen (Rh) in Human Blood Reactions with An.ti-
·Rhesus Sera and with Human Tsoantibodies, J. Exper. Med. 
74:309 (Oct.} 1941. 
20. t'evine, P., Burnham, L., Eng~ewqod, N. J., Katzin, E. M., 
and Vogel, P.: The Role o~· Isoimmunization in the Patho-
genesis of Erythroblastosis Fetalis, Am. J. Obst. & 
Gynec. 42:925 (Dec.) 1941. 11 
1:~21. Wiener, A. S., and Landstein~r, K.: Heredity of Variants 
of the Rh Type, Proc. Soc •. Exper. Biol. & Med. 53:167 
(June) 1943. · 1 
It 
22. Wiener, A. s., and Sonn, E. B.: Additional Variants of 
the Rh Type Demonstratable with a Special Human Anti-Rh 
Serum, J. Immunol. 47:461 (Dec.) 1943. 
23. Wiener, A. s.; Distribution and Heredity of Variants 
of the Rh Type, Sc.i'ence 98:182 (Aug.) 1943. 
24. ''P'hger, L. J., and Wiener, A. S.: Observations on Sensi t-
<ization to the Rh Factor by Blood Transfusion, Am. ,J • 
.. Olin. Path. 15:280 (July) 1945. 
Rage, R. R •• Taylor, G. L., Boorman, K. E.J and Dodd, 
B.bE.: Recognition of Rh Geno~ypes in Man, Nature 
152·::~;.563 (Nov.~ 1943. 
--.. ~---~.-
25. Louti t, J •. F.: Human Blood Groups, Nature 153: 9'7 (Jan.) 1944. 
2'7. Wiener, A. S.: The Rh Factors in Relation fo Clinical 
Medicine, Knn.. o.f Allergy 3:229 (May-June) 1945. 
28. Wiener, A. S., Sonn, E. B., and Belkin, R. B.: D~stri­
bution and_ Heredity of the Human Blood Properties.~ A.;. B, 
M, N, Pan~ Rh, J. Immunol. 50:341 (June) 1945. 
29. 
30. 
31. 
32. 
33. 
34. 
35. 
35. 
3'7. 
38. 
39. 
Race, R. R., Taylor, G. L.; Cappell, D. F., and McFarlane, 
M. N.: Recognition of a Further Common Rh Genotype in 
Men, Nature 153: 52 (Jan.) 1944. 
Wiener, A. S.: A New Test (Blocking Test) for Rh' 
Sensitization, Proc. Soc. Exper.-Biol. & Med. 55:i'73 
(June) 1944. 
Race, R. R., and Taylor, G. L.: The Incomplete Antibody 
in Rn Immunization, Brit. M. J. 2:'755 (Dec. 9) 1944. 
Race, R. R., and Taylor, G. L.: A Serum that Discloses 
the Genotype of Some Rh Positive ~eople, Nature 15.2:300 -
(Sep~.) 1943. '· 
Wiener, A. S.: Hemolytic Reaction Following Transfusions 
, of Blood of the Homologous Group: Further Observa:·tions 
on the Role of Property Rh, Particularly in Cases without 
Demonstratable Isoantibodies, Arch. Path. 32:22'7 (~ug.} 
1941. . 
Murray, J., Race, R. R., and Taylor, G. L.: Serological 
Reactions Caused by the Rare Human Gene Rhz, Nature 155: 
112 (Jan.) 1945. 
Callender, s., Ra~e, R. R., and Paykoc, z. V.: Hyper-
sensitivity to Transfused Blood, .Brit. M. J. 2:83 
(July .21) 1945. 
Landsteiner, K., Wiener, A. s., and Niatson, G. A.: Distri 
bution of the Rh Factor in American Indians, J. Exper. 
Me d • '7 5 :. 7 3 (July) 1'9 42 • 
' . 
Waller, R. K., .and Levine, P.: On the Rh and Other Blood 
Factors in Japanese, Science 100:453 (Nov.) 1944. 
Hooker, s. B.: Isoimmunization in Relation to Intra-group 
Hemolytic Transfusion Reactions, New EnglQnd J. Mea..· 
225:8'71 (Nov. 2'7) 1941. 
Hess, C. B.: The Rh Factor in Pregnancy, Am. J. M ,. Sc. 
209•804 {June) 1945. 
0 
0 
40. Race, R. R.: An 'Incomplete' Antibody in Human Serum 
Nature 153:771 (dune)l944. ' 
41. Taylor, G. L. and Race, R. R.: Hemolytic Disease of 
the Newborn; The Preponderance of Homozygous Fa'thers, 
Brit. M.d. 1:288 (Feb.) 1944. 
42. Murray, d.: A Nomenclature of Subgroups of the Rh 
Factor, Nature 154;701 (Dec.) 1944. 
43. Wiener, A. S.: Theory and Nomenclature of the Hr Blood 
Factors, Science 102:479 (Nov.) 1945. 
44. Race, R. R., McFarlane, M., and Cappel!, D. F.: Anti-Hr 
Serum of Levine, Nature 155:542 (May) 1945. 
45. Wiener, A. S.: The Rh Series of Allelic Genes, Science 
100:595 (Dec.} 1944. 
46. Wiener, A. s., Davidsohn, I., and Potter, ,E. L.: Heredit 
of the Rh Blood Types, d. Exper. Med. 81:63 (Jan.) 1945. 
47. Diamond, L. K., and Abelson, N. M.: The Importan<j-9 of 
Rh Inhibitor Substance in Anti-Rh Serum, J. Olin.·: 
Investigation 24:122 (dan.)~l945. 
I 
48. Wiener, A. s.: The Rh Blood Types_ and Some of Their 
Applications, Am. d. Olin. Path1 15:106 (Mar.) 1945. 
49. :Fisk, R. T., and Morrow, P.: The,,Occurrence of A:p.ti-Rho 
Blocking Antibodies in Anti-Rh' Serum, Proc. Soc. Exper. 
Biol .. & Med. 58:72 (dan.} 19·45. 
50. Wiener, A. S.: Role of the Rh Factor in Blood Tra~sfusion 
War Med. 7: 142 (Feb.) 1945. 
51. DeGowin, E. L.: Isoimmunity to the Rh Factor as a Cause 
of Blood Transfusion Reactions, J. Lab. & Clin. Med. 30: 
9 9 ( Feb • ) 19 45 • 
52. Davidsohn, I.: Rh Antibodies, Am. d. Clin. Path. 15:95 
(Mar.} 1945. 
53. Levine, P.: Prevention of Unintentional Isoimmunization 
of the Rh Negative Female Population, J. A.M. A. '128:946 
(July) 1945. 
54. Young, L. E., and Kar.iher, D. H.: Hemolytic Trans.fus<io.n 
Reactions Due to Rh Incompatibility, J. A. M. A. 1127:627 
(Mar. 17} 1945. 
55. Levine, P., and Stetson, R. E.: An Unusual Case, of 
I~tra-group Agglutination, J. A.M. A. 113:126 (July)8) 
1939. 
56. Levine, P., and Pol~yes, S. H.: An Atypical Hem9lysin 
in Pregnancy,~. Int. Med. 14:1903 (Apr.) 1941. 
57. Burnham, L., and Englewood, N. J.: The Common Etiology 
of Erythroblastosis and Transfusion Accidents in 
Pregnancy, Am. J. Obst. & Gynec. 42:389'(May) 1941. 
58. Dockeray, G. c., and Sachs, H.: Rh Antibodies in the 
Maternal Circulation without Clinical Manifestations of 
Erythroblastosis in the Child, J. Immunol. 48:241 (Apr.) 
1944. 
59. Lubinski, H., Benjamin, B., and Strean, G. J.: Obser-
vations on the Rh Factor in I~s Relation to Hemolytic 
Anemia of the Newborn Infant, Am. J. Obst. & Gyn~c. 
48:464 (Oct.} 1944. 
I 
60. Gunson, J.D.: Hemolytic Dise~se of the Newborn 
(Erthroblastosis Foetalis). Its Treatment with Rhesus 
Negative Blood, Brit. M. J. 2:293 (Sept. 4) 1943. 
61. Race, R. R., Taylor, G. L., Cappell, D. F., and M',bFarlane 
M. N.: The Rh Factor and Erythroblastosis Fetalis. An 
Investigation of 50 Families, Brit. M. J. 2:289 (Sept. 4) 
1943. 
62. Seldon, T. H., Lundy, J. S., and Adams, R. 0.: The Rh 
Factor, Surgical Clinics of N. A. 24:822 (Aug.) 1944. 
63. Stratton, F.: Demonstration of Rh Factor in Blood of 
a 48 mm. Embryo, Natura 152:449 (Oct.) 1943. 
64. Reynolds, P. A.: The Clinical Smgnificance of the Rh 
Factor, West. J. Surg. 52:103 (Ma~.) 1944. ' 
" 
65. Witebsky, E., Anderson, G. w., and Heide, .A.: .Demon-
stration of the Rh Antibody in Breast Milk, Proc. Soc. 
Exper. Bi.ol. & Med. 49:179 (Feb.) 1942. 
66. Witebsky, E., and Heide, A.: Further Investigatiqn on 
Presence of R~ Antibodies in Breast Milk, Proc. Soc. 
Ex:per. Biol. & Med. 52:280 (.Apr.) 1943. . .. 
o?. 
68. 
Halperin, J., Jacobi, M., and Dubin, A.: The Rh F,actor 
in Obstetrics, Am. J. Obst. & Gynec. 50:326 (Sept.) 1945. 
I, 
Neter, E.: Observations on Abnormal Isoantibodies! 
Followin~ Transfusions. J. Immunol. 30:255 (Mar.) 1936. 
J 
0 
69. Frisch, Capt. A. w.z 
Due to the Rh Factor. 
210:184 (Aug.) 1945. 
Hemolytic Transfusion Reactions 
Report of 2 Gases, Am. ~ .. M. Sc. 
70. Beck, A., Harrison, G. V., and Owen, ~. M.: A Severe 
Haemolytic Transfusion Reaction Due to the Rh Fa.'ctor 
Brit. M. ~. 2:180 (Aug.) 1944. ' 
71. 
72. 
73. 
74. 
75. 
78. 
77. 
76. 
'?fl. 
aa. 
Plant, G., Barrow, M. L., and Abbott, J. M.: The Resultf= 
of Routine Investigation for Rh Factor at theN. w. 
London Depot, Brit. M. ~. 2:273 (Sept.) 1945. 
Drummond, R., Taylor, G. L., and Edwards, J. T. R.l 
Potent Anti-Rh Agglutinins Developed in an Rh Negative 
Female after Multiple Transfusions of Rh Positive Bl0od, 
Brit. M. ~. 1:584 (Apr.) 1945. - ' 
van Dorsser, G. ~. E., M:orrison, A. w., and Philpott; 
N. W.: Some Studies on the Rh Factor and Its Signifi~ 
cance in Obstetrical Practice, Canad. M.A.~. 5d:219 
(Mar • ) 1944. 
Hunt, A. B.: The Rh Factor in Repeated Abortion and 
Miscarriage, Proc. Ste.ff Meet., Mayo Olin. 20:26 
(~an. 24) 1945 
Schwartz, H. A., and Levine, P.: Studies on the Rh 
Factor, Am.~. Obst. & Gynec. 46:827 (Dec.) 1943.'' 
Snyder, L. H., Schonfeld, M.D., and Afferman, E. M.: 
The Rh Factor and Feeblemindedness, ~. Hered. 36:9 
(Jan.) 1945. 
I 
Yannet, H., and Lieberman, R.: The Rh Factor in the 
Etiology of Mental Deficiency, P..m. J. Mental Defic•iency 
49:133 (Oct.) 1944. 
carter B. B.: The Production of Rh Antiserum in Guinea 
Pigs Through Inoculation with Human Red Blood Cells, 
Am. J. Olin. Path. 15:278 (July) 1945. 
Hill J". 'M., Haberman, S., and Orozco, A. V.: The, 
Prep~ration of Potent Anti-Rh Typing Serum by Injection 
of Rh ~ositive Blood into Previously Isoimmunized . 
Individuals, J. A.M. A. 128:944 (July) 1945. 
de Torregrosa, M. V.: Inhibition of the Alpha and Bet~ 
Isoagglutinins in Anti-Rh Serum, Proc. Soc. Exper. 
Biol. & Med. 58~329 (Apr.) 1945. 
o. 
~ 
~~ 
\ 
81. Das Gupta, c. R.: A Preliirumary Note on the Preparation 
of Anti-Rh Agglutinin, Indian M. Gaz. 79:372 (Aug.) 1944. 
82. Diamond, L. K., and Abelson, N. M.: The Detection of 
Rh Sensitization: Evaluation of Tests ~or Rh Antibodies, 
J. Lab._& Olin. Med. 30:668.(Aug.) 1945 • 
. 
83. Coombs, R. R. A., Mourant, A. E., and Race, R. R.: De-
tection of Weak and "Incompletett Rh Agglutinins: A New 
Test, Lancet 2:15~ (July) 1945. 
84. Diamond, L. K., and Abelson, N. M~: The Demonstration 
of the Anti-Rh Agglutinins--An Accurate and Rapid Slide 
Test, J. Lab. & Clin. Med. 30:204 (Mar.) 1945. 
85. Wiener, A. S.: Conglutination Test fo.r Rh Sensitization, 
J. Lab. & Olin. Med. 30:662 (Aug.) 1945. ' 
86. Diamond, L. K., and Denton, R. L.:"" Rh Agglutinatlon 
in Various Media with Particular Reference to the Value 
of Albumin, J. Lab. & Olin. Med. 30:821 (Oct.) 1945. 
87. Mourant, A. E.: A New Rhesus Antibody, Nature 155:542 
(May) 1945. 
88. Speck, G., and Sonn, E. B.: An Int.ra-g..roup Hemolytic 
Transfusion Reaction in an Rh Positive Patient,~· J. 
Obst. & Gynec. 49:273 (Feb.) 1945. 
89. Levine, P.: Isoimmunization by the Rh Factor--A New 
Cause of Fetal and Neonatal Morbitity, Human Ferti,lity 
9:65 (Sept.) 1944. 
90. Levine, P.: The Pathogenesis of Erythroblastosis 
Fetalis. A Review, J. Pediat. 23:656 (Dec.) 1943. 
Ql. Diamond, L. K.: Personal Communication. 
Wiener, A. s., Sonn, E. B., and Belkin,~~. B.: The 
Nature of Rh Agglutination Reactions, Science 100:98 
(Aug.) 1944. / 
:Race R. R., and T~yior, G. L.: The Rare Gene Rhy' in 
Moth~r and Son, Nature 153:560 (May} 1944. 
I Yiak, R. ~~, and Foard, A. G.~ Further Ob~ervations 
tllc Rh Agglutinogen: Stud~es on an Ant~-Rh Serum ~~unusual Specificity ~nd the Occurr~nce of ~he ~~me 
Agglutinins in Breast M~lk, Am. J. C1~n. Path. 14.431 
(Aug. ) 1944. 
·~ 
,, 
, I 
I! 
1 
